← Eichor
Study identifier: NCT06162884 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Condition: Pulmonary Fibrosis  ·  Sponsor: University of California, Los Angeles

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Single Time point Prediction (STP) is a score derived from an artificial intelligenc/ machine learning (AI/ML) using the radiomic features from a HRCT scan that quantifies the imaging patterns of short-term predictive worsening.

This description comes directly from the study's public registry record.

Talk to the study team

Grace Hyun Kim, PhD  ·  (310) 481-7594  ·  GraceKim@mednet.ucla.edu

Claudia L Perdomo, AS  ·  310-267-4707  ·  cperdomo@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UCLALos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06162884